You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 12, March 22, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  CONCEPTS IN EMERGENCY AND CRITICAL CARE
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (26)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Management of Pneumonias in Immunocompromised Patients

Henry Masur, MD; James Shelhamer, MD; Joseph E. Parrillo, MD

JAMA. 1985;253(12):1769-1773.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

LIFE-THREATENING disease can develop in immunosuppressed patients due to a myriad of potential pathogens causing disease in virtually any organ system in the body. The prompt diagnosis and appropriate treatment of these infectious processes are essential to limiting their extent and duration and are vital to the prolongation of these patients' lives. Pneumonia is a particularly important cause of life-threatening infection in these populations because it is so frequent, because specific diagnoses can be established in a high percentage of cases, and because specific effective therapy is available for many of these diagnostic possibilities. Thus, the diagnosis and management of pneumonia in immunosuppressed patients are essential skills for any physician who deals with this patient population.

During the last decade, a number of important developments regarding pneumonitis have occurred: the range of recognized pulmonary pathogens has expanded, progress has been made in developing new noninvasive and invasive diagnostic techniques, and . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Critical Care Medicine, Clinical Center, National Institutes of Health, Bethesda, Md.


Footnotes

Reprint requests to Department of Critical Care Medicine, Clinical Center, Bldg 10, Room 10-D-48, National Institutes of Health, Bethesda, MD 20205 (Dr Parrillo).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.